Government Of Quebec Has Expanded Public Reimbursement Of Abbott's FreeStyle Libre 2 Flash Glucose Monitoring System To More Adults With Diabetes
Portfolio Pulse from Benzinga Newsdesk
The Government of Quebec has expanded public reimbursement for Abbott's FreeStyle Libre 2 Flash Glucose Monitoring System to more adults with diabetes. This update, effective from July 4, 2024, will benefit individuals 18 years and older with type 1 or type 2 diabetes who are treated with intensive insulin and meet specific criteria.
August 08, 2024 | 1:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
The Government of Quebec has expanded public reimbursement for Abbott's FreeStyle Libre 2 Flash Glucose Monitoring System to more adults with diabetes. This update, effective from July 4, 2024, will benefit individuals 18 years and older with type 1 or type 2 diabetes who are treated with intensive insulin and meet specific criteria.
The expanded reimbursement by the Government of Quebec for Abbott's FreeStyle Libre 2 is likely to increase the product's adoption among adults with diabetes. This could lead to higher sales and revenue for Abbott, positively impacting its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100